Canada veterinary healthcare market is primarily driven by the increasing animal adoption, the rising burden of animal diseases coupled with an increase in spending on animal health. Canada has high increased awareness regarding companion animals and livestock, considering the increasing adoption of these animals for social well-being and a healthy lifestyle. The business is mainly driven by the rising ownerships, as well as the technological advancements in therapeutics and diagnostics.? According to the Canadian Animal Health Institute (CAHI), in 2018, there were 8.3 million cats and 8.2 million dogs in Canada. The same report has stated that at least 41% of households have at least one dog and 38% of the households have at least one cat.

Considering the risk of transferring human diseases to animals and vice versa, the recent years have observed increased medications and diagnostics treatment for companion animals. Moreover, this has provided high business demands for diagnostic imaging and molecular diagnostics tests across the country.?

In addition, there is an increasing demand for analgesics, antibiotics, anti-inflammatory drugs, and anaesthetics followed by biologics and vaccines. These are regulated by several agencies across Canada.

Key Market Trends

The Vaccines Segment Dominates the Canada Veterinary Healthcare Market

  • Vaccines comprise viruses, bacteria, or other disease-causing organisms that have been killed or attenuated so that they cannot cause further disease and can boost immunity.
  • Veterinary biologics, like vaccines, are regulated by the Canadian Food Inspection Agency, to ensure that the products used on animals in Canada are pure, potent, safe, and effective. The import of veterinary vaccines to Canada needs a valid import permit, issued by the CFIA-CCVB in Ottawa.
  • In some parts of Canada, it is mandatory to vaccinate every cat and dog, where there are high risks of rabies. According to the veterinary community of Canada, every dog should be vaccinated with core vaccines.
  • Furthermore, several initiatives have been undertaken by Canada. For instance, a public awareness campaign was organized in September 2018, by the Canadian Veterinary Medical Association (CVMA), hosted by veterinarians, to showcase the importance of vaccines.
  • Morover, recent advancements and availability of vaccines, new product launches projected to fuel the sgemnet growth over the forecast period.
  • In January 2019, Hipra Canada launched VEPURED, the latest vaccine to control edema disease in its clinical and subclinical form. Thus, the market for veterinary healthcare in Canada projected to grow over forecast period.



Competitive Landscape

The Canadian veterinary healthcare market has rapidly evolved over the last few years. The industry observed significant mergers and acquisitions, in recent years. For instance, Ehave, Inc. which is dedicated to empowering the mental health community with next-generation digital solutions, is expanding its business into veterinary medicine in Canada in 2017. The company to license core informatics platform to Companion Healthcare Technologies, Inc. for improving the quality of care for pets. ? The major companies in the Canadian veterinary healthcare market include Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco (Eli Lilly and Company), Idexx Laboratories, Merck Animal Health, Virbac Corporation, Vitoquinol SA, and Zoetis Animal Healthcare, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support